Burden, Access, and Disparities in Kidney Disease
- PMID: 30820003
- DOI: 10.1159/000497540
Burden, Access, and Disparities in Kidney Disease
Abstract
Kidney disease is a global public health problem, affecting over 750 million persons worldwide. The burden of kidney disease varies substantially across the world. In many settings, rates of kidney disease and the provision of its care are defined by socioeconomic, cultural, and political factors leading to significant disparities. World Kidney Day 2019 offers an opportunity to raise awareness of kidney disease and highlight disparities in its burden and current state of global capacity for prevention and management. Here, we highlight the need for strengthening basic infrastructure for kidney care services for early detection and management of acute kidney injury and chronic kidney disease across all countries and advocate for more pragmatic approaches to providing renal replacement therapies. Achieving universal health coverage worldwide by 2030 is a World Health Organization Sustainable Development Goal. While universal health coverage may not include all elements of kidney care in all countries, understanding what is locally feasible and important with a focus on reducing the burden and consequences of kidney disease would be an important step towards achieving kidney health equity.
Keywords: Acute kidney injury; End-stage renal disease; Global health; Health equity; Social determinants of health.
© 2019 World Kidney Day 2019 Steering Committee.
Similar articles
-
Burden, access, and disparities in kidney disease.Clin Nephrol. 2019 Mar;91(3):129-137. doi: 10.5414/CN91WKDEDI. Clin Nephrol. 2019. PMID: 30704553
-
Burden, access, and disparities in kidney disease.Pediatr Nephrol. 2019 Apr;34(4):541-548. doi: 10.1007/s00467-019-4197-2. Pediatr Nephrol. 2019. PMID: 30758679
-
Burden, access and disparities in kidney disease.J Ren Care. 2019 Mar;45(1):4-8. doi: 10.1111/jorc.12269. J Ren Care. 2019. PMID: 30784230
-
Socioeconomic disparities in chronic kidney disease.Adv Chronic Kidney Dis. 2015 Jan;22(1):6-15. doi: 10.1053/j.ackd.2014.07.002. Adv Chronic Kidney Dis. 2015. PMID: 25573507 Free PMC article. Review.
-
Chronic kidney disease in disadvantaged populations.Braz J Med Biol Res. 2015 May;48(5):377-81. doi: 10.1590/1414-431X20144519. Epub 2015 Mar 6. Braz J Med Biol Res. 2015. PMID: 25760025 Free PMC article. Review.
Cited by
-
Single-Cell Profiling Reveals Sex, Lineage, and Regional Diversity in the Mouse Kidney.Dev Cell. 2019 Nov 4;51(3):399-413.e7. doi: 10.1016/j.devcel.2019.10.005. Dev Cell. 2019. PMID: 31689386 Free PMC article.
-
Effect of MAFLD on albuminuria and the interaction between MAFLD and diabetes on albuminuria.J Diabetes. 2024 Feb;16(2):e13501. doi: 10.1111/1753-0407.13501. Epub 2023 Nov 16. J Diabetes. 2024. PMID: 37974383 Free PMC article.
-
Association of MAFLD with end-stage kidney disease: a prospective study of 337,783 UK Biobank participants.Hepatol Int. 2023 Jun;17(3):595-605. doi: 10.1007/s12072-023-10486-0. Epub 2023 Feb 21. Hepatol Int. 2023. PMID: 36809487
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical